-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - Combining whole brain radiotherapy with target
drug for non-small cell lung cancer with multiple brain … Food and Drug Administration. What is a Serious Adverse Event?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
December 19, 2016 - criteria, such as
delivery of care to children with developmental
disorders only, and settings such as drug … TEP 6 General Second, the authors list an exclusion criteria of
“Interventions targeting only… drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
April 02, 2015 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Omega 3 Fatty Acids and Cardiovascular Disease -- Update
I. Background and Objectives for the Systematic Review
The Office of Dietary Supplements (ODS), the National Institutes of Health
(NIH), has a long history of commissioning AHRQ-based…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
January 17, 2017 - perioperative use of opioids; however,
our KQ did not address perioperative opioid use
given US Food and Drug … published before
2000 and thus not eligible for inclusion in the
current review, in which we addressed drug
-
effectivehealthcare-admin.ahrq.gov/products/radiation-brain-metastases/protocol
June 01, 2021 - Combining whole brain radiotherapy with target drug for non-small cell lung cancer with multiple brain … Food and Drug Administration. What is a Serious Adverse Event? Accessed on October 10, 2019.
-
effectivehealthcare-admin.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
December 01, 2020 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatic-fibrosis_white-paper.pdf
April 01, 2014 - Strategies
for obtaining unpublished drug trial data: a
qualitative interview study. … Progression of liver fibrosis among
injection drug users with chronic hepatitis C. … Progression of liver fibrosis among
injection drug users with chronic hepatitis C.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
September 11, 2015 - Department of Health and Human Services, Food
and Drug Administration, Center for Drug Evaluation
and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
January 01, 2011 - Network: www.researchadvocacy.org
– Roadmap to Research Advocacy
– Advocate Institute
• Food and Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/documentation-burden-protocol.pdf
July 26, 2023 - Food and Drug Administration,
ClinicalTrials.gov, Health Canada, U.K.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
August 05, 2010 - What is
the current the Food and Drug Administration (FDA) clearance status of these
positional MRI
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
January 01, 2018 - substance
use and mental health indicators in the United States: Results from the 2019 National
Survey on Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - This drug also has the
potential for off-label use in other patient populations. … Abstract Review
Level*
No original data = 4,150
Does not evaluate a population of interest = 1,401
Drug … conducted in humans = 6
Does not evaluate a population of interest = 976
Treatment of VTE = 135
Comparator drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - Patient: Adults with episodic migraine
Intervention: Systemic opioid abortive therapy, nonopioid abortive drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - or uncertainty).ti,ab.
27 Delivery of Health Care/ or exp Disease Management/ or "Drug-Related … or "disease
management" or "drug effects" or "inappropriate prescrib*" or "medical error?"
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
December 18, 2019 - Disease Control and Prevention
CR Cervical ripening
EPC Evidence-based Practice Center
FDA Federal Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - Source: www.effectivehealthcare.ahrq.gov
Published Online: October 17, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Meditation Programs for Stress and Well-Being
Amendment Date(s) if applicable: October 10, 2012
(Amendments Details–see Section VII)
I. Background
Me…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
January 12, 2022 - 22
RCT hedge (sensitive)
((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/telehealth-women-protocol.pdf
June 21, 2021 - Food and Drug Administration; HDI = human development index
rating; KQ = key question; RCT = randomized
-
effectivehealthcare-admin.ahrq.gov/products/cervical-ripening/protocol
May 01, 2020 - Prevention
CR
Cervical ripening
EPC
Evidence-based Practice Center
FDA
Federal Drug